Clinical trial
Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors
NCT00006485 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006485 |
|---|---|
| Title | Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors |
| Official title | An Open-Labeled, Non-Randomized Phase I Study Of Flavopiridol Administered With Irinotecan (CPT-11) In Patients With Advanced Solid Tumors |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | alvocidib, irinotecan hydrochloride |
| Start date | Sep 1, 2000 |
| Primary completion | Dec 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 15, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: